2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92587°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
°úÇÐ, Äڷγª19 È®»êÀ¸·Î Á߿䵵 ºÎ»ó (2020-11-14)
ÇÏÀÌÆÛ·çÇÁ ù À¯ÀÎ ÁÖÇà ¾ÈÀüÇÏ°Ô ¼º°ø (2020-11-14)
Àα³Áø-¼ÒÀÌÇö ºÎºÎ, ŰÀ̽ºÆ®¿Í Àü¼Ó°è¾à (2015-06-22)
NHN¿©Çà¹Ú»ç, ¼öÇè»ý ÃÖ´ë 10¸¸¿ø ÇÒÀÎ À̺¥Æ® (2019-11-14)
Çö´ë±â¾ÆÀÚµ¿Â÷±×·ì, À̽º¶ó¿¤°ú ¹Ì·¡ »ê¾÷ Çù·Â (2019-07-15)
SKT, MS¿Í ÷´Ü ICT ºÐ¾ß Æ÷°ýÀû Çù·Â °­È­ (2019-05-15)
Á¤ºÎÇÕµ¿ ¡®Ä·ÆÛ½º Çõ½ÅÆÄÅ© Á¶¼º¹æ¾È¡¯ ¹ßÇ¥ (2019-05-15)
ÄÚ¸®¾ÆÅØ, °úÇк§Æ® ±â´ÉÁö±¸ â¾÷¼ºÀå»ç¾÷ ¼±Á¤ (2019-05-15)
'¾ÇÀÇ ¸¶À½À»' ·Á¿î, ¸·³» Çü»ç Ȱ¾à ±â´ë°¨ (2022-01-25)
ÀýÁÖÈ«º¸´ë»ç Å©·¹¿ëÆË, ºüºüºü °³»çÇÑ ¡®ÀýÁÖ¼Û¡¯ °ø°³ (2013-12-30)
ÈÆ¹ÎÁ¤À½ÀÇ Àçź»ý, NFT·Î ÇѱÛÀÇ ¼¼°èÈ­ (2021-07-26)
SKÅÚ·¹ÄÞ e½ºÆ÷Ã÷ ±â¾÷ T1, ÇϳªÀºÇà°ú ÆÄÆ®³Ê½Ê (2020-07-25)
¾Æºü°¡ µ¹¾Æ¿Ô´Ù¡¦ÆÐ¹Ð¸®·è ÃÖ°­ÀÚ´Â ¼Ç°ú Ãß¼ºÈÆ (2014-01-09)
¾È·¦ V3, AV-TEST ±Û·Î¹ú ÀÎÁõ ȹµæ (2015-04-01)
¼­¿ï½Ã, »ý°úÀÏÁÖ½º Àü¹®Á¡ 31°³¼Ò ¡®´ç ÇÔ·®¡¯ Á¶»ç (2018-08-03)
¡®±ÂÀâ 5060¡¯ ½ÅÁß³â Âü°¡ÀÚ 54% ÀçÃë¾÷ (2019-12-04)
Á¦ÀÏÁ¦¸é¼Ò ¼­¿ï¿ª»çÁ¡ ¹Ì·¡Çü ½º¸¶Æ® ¸ÅÀå µµÀÔ (2020-02-03)
ÇØÇǶóÀÌÇÁ, KF¸¶½ºÅ© ¹Ì±¹ ¼öÃâ °è¾à (2020-12-04)
SKÅÚ·¹ÄÞ, T¸Ê ¾Èµå·ÎÀÌµå ¿ÀÅä º£Å¸ Å×½ºÆ® (2020-12-04)
KF¼¼°è¿µÈ­ÁÖ°£, ³×À̹öTV ÅëÇØ »ó¿µÀÛ °ø°³ (2020-12-04)
NBA¿Í 18K °ñµå ¹× Ä¿½ºÅÒ ¾×¼¼¼­¸® Ä÷º¼Ç (2021-02-03)
¡®Çìµå À¯´Ö ¿¬µ¿Çü ÀüÀÚ¿ä±Ý ¡¼ö ÀåÄ¡¡¯ Áß±¹ ƯÇã (2021-12-05)
Çö´ëÂ÷, ¡®Ä³½ºÆÛ ¹ê¡¯ Ãâ½Ã (2022-02-04)
Mary Kay Awards Education Grant to Young Woman Aspiring to B... (2022-10-06)
19ÀϺÎÅÍ ¹«·á ´ëÇ¥¹øÈ£ 14¡Û¡Û¡Û¡Û ¼­ºñ½º °³½Ã (2019-04-14)
       [ÀÌÀü][1]....[3122][3123][3124][3125][3126][3127][3128][3129][3130]...[3704][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..